UY27413A1 - Agonistas de la oxitocina - Google Patents

Agonistas de la oxitocina

Info

Publication number
UY27413A1
UY27413A1 UY27413A UY27413A UY27413A1 UY 27413 A1 UY27413 A1 UY 27413A1 UY 27413 A UY27413 A UY 27413A UY 27413 A UY27413 A UY 27413A UY 27413 A1 UY27413 A1 UY 27413A1
Authority
UY
Uruguay
Prior art keywords
agonists
oxychocine
compounds
ositocin
nr5r6
Prior art date
Application number
UY27413A
Other languages
English (en)
Inventor
Gary Robert William Pitt
David Philip Rooker
Andrzej Roman Batt
Celine Marguerite Simo Laurent
Michael Bryan Roe
Peter Jeremy Hudson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of UY27413A1 publication Critical patent/UY27413A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Abstract

Los compuestos de acuerdo con la fórmula general 1, donde G1 es NR5R6 o un grupo policíclico fusionado con novedosos. Son agonistas selectivos y potentes de la ositocina. Las composiciones farmacéuticas de tales compuestos son útiles en el tratamiento de, por ejemplo, la disfunción eréctil.
UY27413A 2001-08-16 2002-08-12 Agonistas de la oxitocina UY27413A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0120051.8A GB0120051D0 (en) 2001-08-16 2001-08-16 Oxytocin agonists

Publications (1)

Publication Number Publication Date
UY27413A1 true UY27413A1 (es) 2003-02-28

Family

ID=9920554

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27413A UY27413A1 (es) 2001-08-16 2002-08-12 Agonistas de la oxitocina

Country Status (18)

Country Link
US (1) US20050032777A1 (es)
EP (1) EP1421087A1 (es)
JP (1) JP2005501858A (es)
KR (1) KR20040023728A (es)
CN (1) CN1285594C (es)
AR (1) AR042591A1 (es)
CA (1) CA2453962A1 (es)
GB (1) GB0120051D0 (es)
HK (1) HK1071132A1 (es)
IL (1) IL159821A0 (es)
MX (1) MXPA04001447A (es)
NO (1) NO20041819L (es)
NZ (1) NZ530587A (es)
PL (1) PL367543A1 (es)
RU (2) RU2311417C2 (es)
UY (1) UY27413A1 (es)
WO (1) WO2003016316A1 (es)
ZA (1) ZA200400272B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
EP1449844A1 (en) * 2003-02-14 2004-08-25 Ferring B.V. benzamide derivatives as oxytocin agonists and vasopressin antagonists
NZ544449A (en) 2003-06-23 2008-10-31 Cv Therapeutics Inc Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
EP1512687A1 (en) * 2003-09-05 2005-03-09 Ferring B.V. Piperazines as oxytocin agonists
EP1632494A1 (en) * 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
RU2008114374A (ru) * 2005-10-24 2009-12-10 Вайет (Us) Трициклические соединения, применяемые в качестве агонистов рецептора окситоцина
GB0903493D0 (en) 2009-02-27 2009-04-08 Vantia Ltd New compounds
GB201004677D0 (en) 2010-03-19 2010-05-05 Vantia Ltd New salt
CA2799733A1 (en) 2010-05-18 2011-11-24 Universite De Geneve New uses of oxytocin-like molecules and related methods
ES2595251T3 (es) 2010-05-25 2016-12-28 Inserm - Institut National De La Santé Et De La Recherche Médicale Métodos y composición farmacéutica para el tratamiento de un trastorno alimentario con inicio temprano en un paciente
CN103159641A (zh) * 2011-12-14 2013-06-19 天津泰普药品科技发展有限公司 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法
MX2019006942A (es) * 2016-12-12 2019-10-21 Univ Sydney Agonistas de receptores de oxitocina no peptidicos.
CN113429379A (zh) * 2021-06-28 2021-09-24 江苏法安德医药科技有限公司 一种lh-1801中间体及其制备方法和应用
CN116120261B (zh) * 2022-11-30 2024-01-23 浙大宁波理工学院 一种3-[（4-磺胺哌嗪-1-基）甲基]苯甲酸类化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116334A1 (en) * 1992-07-02 1994-01-20 Hidenori Ogawa Oxytocin antagonist
AR011913A1 (es) * 1997-03-06 2000-09-13 Yamano Masaki Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
JPH111456A (ja) * 1997-06-13 1999-01-06 Otsuka Pharmaceut Co Ltd アミド誘導体
US5968938A (en) * 1997-06-18 1999-10-19 Merck & Co., Inc. Piperazine oxytocin receptor antagonists
GB2326639A (en) * 1997-06-18 1998-12-30 Merck & Co Inc Piperazine Oxytocin Receptor Antagonists

Also Published As

Publication number Publication date
NO20041819L (no) 2004-05-14
RU2311417C2 (ru) 2007-11-27
WO2003016316A8 (en) 2003-10-02
KR20040023728A (ko) 2004-03-18
IL159821A0 (en) 2004-06-20
CN1543467A (zh) 2004-11-03
GB0120051D0 (en) 2001-10-10
PL367543A1 (en) 2005-02-21
NZ530587A (en) 2004-12-24
RU2007121219A (ru) 2008-12-20
EP1421087A1 (en) 2004-05-26
JP2005501858A (ja) 2005-01-20
AR042591A1 (es) 2005-06-29
HK1071132A1 (en) 2005-07-08
CN1285594C (zh) 2006-11-22
US20050032777A1 (en) 2005-02-10
CA2453962A1 (en) 2003-02-27
MXPA04001447A (es) 2004-07-08
ZA200400272B (en) 2004-11-18
RU2004101060A (ru) 2005-06-27
WO2003016316A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
UY27413A1 (es) Agonistas de la oxitocina
DK1399436T3 (da) Oxytocinagonister
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
PA8503301A1 (es) Compuestos para el tratamiento de la isquemia
UY28150A1 (es) Agentes terapeuticos
PA8465901A1 (es) Nuevos derivados de la eritromicina
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
ATE337316T1 (de) Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
UY27503A1 (es) Nuevos derivados de piperazina
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
GT200100251A (es) Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida
AR044275A1 (es) Uso de derivados de sulfonamidas para la fabricacion de un medicamento para la profilaxis y/o tratamiento de las disfunciones alimentarias
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.
AR032341A1 (es) N-(2-metansulfonil-etil)-n-hidroxiformamidas, su uso en la produccion de medicamentos, composiciones farmaceuticas que las contienen, procedimiento para preparar dichos compuestos e intermediarios para su preparacion
ECSP034533A (es) Derivados sustituyentes 5-amino-1 penteno-3-ol
SE0100296D0 (sv) New compounds
SE0100295D0 (sv) New compounds
SE0303451D0 (sv) New compounds
SE9902147L (sv) Nya föreningar och farmaceutiska kompositioner innehållande desamma
ECSP993209A (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
UY27235A1 (es) Compuestos de dihidropirimidina ciano sustituidos y su uso para tratar padecimientos
DOP2003000766A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
ECSP992905A (es) Compuestos y composiciones farmaceuticas para el tratamiento de la malaria

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150212